Project Number 5R01AG056561-02 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Neuron regenerative therapeutic; NNI-362; for first-in-human safety and PK for AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) e. Neurogenesis Researcher and Organization Principal Investigator KELLEHER-ANDERSSON, JUDITH A Principal Investigator First Name JUDITH Principal Investigator Last Name KELLEHER-ANDERSSON Awardee Organization NEURONASCENT, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-365: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01) FY Overall Cost $692,120 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
